BV
Biotechnology Value Fund L.P. disclosed a 9.8% stake in OLMA
Biotechnology Value Fund L.P. reported owning 9.8% of Olema Pharmaceuticals, Inc. (OLMA) (8,939,731 shares) in a Schedule 13D filed Oct 16, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Oct 16, 2026
- Source
- Schedule 13D